{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:22:54Z","timestamp":1747207374743,"version":"3.40.5"},"reference-count":177,"publisher":"Bentham Science Publishers Ltd.","issue":"15","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPB"],"published-print":{"date-parts":[[2019,11,22]]},"abstract":"<jats:sec><jats:title\/><jats:p>Statins are drugs used for people with abnormal lipid levels (hyperlipidemia) and are among the best-selling medications in the United States. Thus, the aspects related to the production of these drugs are of extreme importance for the pharmaceutical industry. Herein, we provide a non-exhaustive review of fungal species used to produce statin and highlighted the major factors affecting the efficacy of this process. The current biotechnological approaches and the advances of a metabolic engineer to improve statins production are also emphasized. The biotechnological production of the main statins (lovastatin, pravastatin and simvastatin) uses different species of filamentous fungi, for example Aspergillus terreus. The statins production is influenced by different types of nutrients available in the medium such as the carbon and nitrogen sources, and several researches have focused their efforts to find the optimal cultivation conditions. Enzymes belonging to Lov class, play essential roles in statin production and have been targeted to genetic manipulations in order to improve the efficiency for Lovastatin and Simvastatin production. For instance, Escherichia coli strains expressing the LovD have been successfully used for lovastatin production. Other examples include the use of iRNA targeting LovF of A. terreus. Therefore, fungi are important allies in the fight against hyperlipidemias. Although many studies have been conducted, investigations on bioprocess optimization (using both native or genetic- modified strains) still necessary.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1389201020666190718165746","type":"journal-article","created":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T09:00:57Z","timestamp":1563872457000},"page":"1244-1259","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Biotechnological Production of Statins: Metabolic Aspects and Genetic Approaches"],"prefix":"10.2174","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9043-490X","authenticated-orcid":true,"given":"Roberval N.M.","family":"Neto","sequence":"first","affiliation":[{"name":"Pro-reitoria de Pos-Graduacao, Pesquisa e Extensao, Universidade Ceuma, Sao Luis, Maranhao, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4983-6282","authenticated-orcid":true,"given":"Edelvio de","family":"Barros Gomes","sequence":"additional","affiliation":[{"name":"Instituto Federal da Bahia, Salvador, Bahia, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4315-2499","authenticated-orcid":true,"given":"Lucas","family":"Weba-Soares","sequence":"additional","affiliation":[{"name":"Pro-reitoria de Pos-Graduacao, Pesquisa e Extensao, Universidade Ceuma, Sao Luis, Maranhao, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6303-4927","authenticated-orcid":true,"given":"L\u00e9o R.L.","family":"Dias","sequence":"additional","affiliation":[{"name":"Pro-reitoria de Pos-Graduacao, Pesquisa e Extensao, Universidade Ceuma, Sao Luis, Maranhao, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4206-0904","authenticated-orcid":true,"given":"Lu\u00eds C.N.","family":"da Silva","sequence":"additional","affiliation":[{"name":"Pro-reitoria de Pos-Graduacao, Pesquisa e Extensao, Universidade Ceuma, Sao Luis, Maranhao, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2116-1797","authenticated-orcid":true,"given":"Rita de C.M.","family":"de Miranda","sequence":"additional","affiliation":[{"name":"Pro-reitoria de Pos-Graduacao, Pesquisa e Extensao, Universidade Ceuma, Sao Luis, Maranhao, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1161\/ATVBAHA.108.179739","volume":"30","author":"Finn A.K.","year":"2010","unstructured":"Finn A.K.; Nakano M.; Narula J.; Kolodgie F.D.; Virmani R.; Concept of vulnerable\/unstable plaque. Arterioscler Thromb Vasc Biol 2010,30(7),1282-1292","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.2174\/156802609789869628","volume":"9","author":"Tziomalos K.","year":"2009","unstructured":"Tziomalos K.; Athyros V.G.; Karagiannis A.; Mikhailidis D.P.; Dyslipidemia as a risk factor for ischemic stroke. Curr Top Med Chem 2009,9(14),1291-1297","journal-title":"Curr Top Med Chem"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yexmp.2017.06.001","volume":"103","author":"Zimny S.","year":"2017","unstructured":"Zimny S.; Pohl R.; Rein-Fischboeck L.; Haberl E.M.; Krautbauer S.; Weiss T.S.; Buechler C.; Chemokine (CC-motif) receptor-like 2 mRNA is expressed in hepatic stellate cells and is positively associated with characteristics of non-alcoholic steatohepatitis in mice and men. Exp Mol Pathol 2017,103(1),1-8","journal-title":"Exp Mol Pathol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"84","DOI":"10.2174\/1874192401711010084","volume":"11","author":"Rashidi O.M.","year":"2017","unstructured":"Rashidi O.M.; H. Nazar F.A.; Alama M.N.; Awan Z.A.; Interpreting the mechanism of APOE (p. Leu167del) mutation in the incidence of familial hypercholesterolemia; an in-silico approach. Open Cardiovasc Med J 2017,11,84-93","journal-title":"Open Cardiovasc Med J"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1002\/hep4.1110","volume":"1","author":"Omer L.","year":"2017","unstructured":"Omer L.; Hudson E.A.; Zheng S.; Hoying J.B.; Shan Y.; Boyd N.L.; CRISPR Correction of a homozygous low-density lipoprotein receptor mutation in familial hypercholesterolemia induced pluripotent stem cells. Hepatol Commun 2017,1(9),886-898","journal-title":"Hepatol Commun"},{"key":"ref=6","first-page":"78","volume":"95","author":"Last A.R.","year":"2017","unstructured":"Last A.R.; Ference J.D.; Menzel E.R.; Hyperlipidemia: Drugs for cardiovascular risk reduction in adults. Am Fam Physician 2017,95(2),78-87","journal-title":"Am Fam Physician"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.2174\/1568026614666141203130324","volume":"14","author":"Profumo E.","year":"2014","unstructured":"Profumo E.; Buttari B.; Saso L.; Rigano R.; Pleiotropic effects of statins in atherosclerotic disease: Focus on the antioxidant activity of atorvastatin. Curr Top Med Chem 2014,14(22),2542-2551","journal-title":"Curr Top Med Chem"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.2174\/1568026614666140329232252","volume":"14","author":"Romana B.","year":"2014","unstructured":"Romana B.; Batger M.; Prestidge C.A.; Colombo G.; Sonvico F.; Expanding the therapeutic potential of statins by means of nanotechnology enabled drug delivery systems. Curr Top Med Chem 2014,14(9),1182-1193","journal-title":"Curr Top Med Chem"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2174\/1568026053544524","volume":"5","author":"Scharnagl H.","year":"2005","unstructured":"Scharnagl H.; M\u00e4rz W.; New lipid-lowering agents acting on LDL receptors. Curr Top Med Chem 2005,5(3),233-242","journal-title":"Curr Top Med Chem"},{"key":"ref=10","author":"Pertzov B.","year":"2018","unstructured":"Pertzov B.; Eliakim-Raz N.; Atamna H.; Trestioreanu A.Z.; Yahav D.; Leibovici L.; Hydroxymethylglutaryl-CoA reductase inhibitors (statins) for the treatment of sepsis in adults - a systematic review and meta-analysis. Clin Microbiol Infect 2018","journal-title":"Clin Microbiol Infect"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.2174\/0929867324666161118094711","volume":"24","author":"Raparelli V.","year":"2017","unstructured":"Raparelli V.; Pannitteri G.; Todisco T.; Toriello F.; Napoleone L.; Manfredini R.; Basili S.; Treatment and response to statins: Gender-related Differences. Curr Med Chem 2017,24(24),2628-2638","journal-title":"Curr Med Chem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2174\/1389201018666170123153626","volume":"18","author":"Chatelin J.","year":"2017","unstructured":"Chatelin J.; Stathopoulou M.G.; Arguinano A.A.; Xie T.; Visvikis-Siest S.; Pharmacogenomic challenges in cardiovascular diseases: Examples of drugs and considerations for future integration in clinical practice. Curr Pharm Biotechnol 2017,18(3),231-241","journal-title":"Curr Pharm Biotechnol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13613-017-0349-3","volume":"8","author":"Wiewel M.A.","year":"2018","unstructured":"Wiewel M.A.; Scicluna B.P.; van Vught L.A.; Hoogendijk A.J.; Zwinderman A.H.; Lutter R.; Horn J.; Cremer O.L.; Bonten M.J.; Schultz M.J.; van der Poll T.; The host response in critically ill sepsis patients on statin therapy: A prospective observational study. Ann Intensive Care 2018,8(1),9","journal-title":"Ann Intensive Care"},{"key":"ref=14","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0000000000000433","author":"Iarrobino N.A.","year":"2018","unstructured":"Iarrobino N.A.; Gill B.; Bernard M.E.; Mishra M.V.; Champ C.E.; Targeting tumor metabolism with statins during treatment for advanced-stage pancreatic cancer. Am J Clin Oncol 2018","journal-title":"Am J Clin Oncol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40035-018-0110-3","volume":"7","author":"Schultz B.G.","year":"2018","unstructured":"Schultz B.G.; Patten D.K.; Berlau D.J.; The role of statins in both cognitive impairment and protection against dementia: A tale of two mechanisms. Transl Neurodegener 2018,7,5","journal-title":"Transl Neurodegener"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"603","DOI":"10.2174\/156802608783955601","volume":"8","author":"Cunnington A.","year":"2008","unstructured":"Cunnington A.; Nadel S.; New therapies for sepsis. Curr Top Med Chem 2008,8(7),603-614","journal-title":"Curr Top Med Chem"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.bbi.2016.11.006","volume":"60","author":"Reis P.A.","year":"2017","unstructured":"Reis P.A.; Alexandre P.C.B.; D\u2019Avila J.C.; Siqueira L.D.; Antunes B.; Estato V.; Tibiri\u00e7a E.V.; Verdonk F.; Sharshar T.; Chr\u00e9tien F.; Castro-Faria-Neto H.C.; Bozza F.A.; Statins prevent cognitive impairment after sepsis by reverting neuroinflammation, and microcirculatory\/endothelial dysfunction. Brain Behav Immun 2017,60,293-303","journal-title":"Brain Behav Immun"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.ijantimicag.2017.04.005","volume":"49","author":"Ribeiro N.Q.","year":"2017","unstructured":"Ribeiro N.Q.; Costa M.C.; Magalh\u00e3es T.F.F.; Carneiro H.C.S.; Oliveira L.V.; Fontes A.C.L.; Santos J.R.A.; Ferreira G.F.; Araujo G.R.S.; Alves V.; Frases S.; Paix\u00e3o T.A.; de Resende Stoianoff M.A.; Santos D.A.; Atorvastatin as a promising anticryptococcal agent. Int J Antimicrob Agents 2017,49(6),695-702","journal-title":"Int J Antimicrob Agents"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.3389\/fimmu.2018.02137","volume":"9","author":"Braga Filho J.A.F.","year":"2018","unstructured":"Braga Filho J.A.F.; Abreu A.G.; Rios C.E.P.; Trov\u00e3o L.O.; Silva D.L.F.; Cysne D.N.; Nascimento J.R.; Fortes T.S.; Silva L.A.; Guerra R.N.M.; Maciel M.C.G.; Serezani C.H.; Nascimento F.R.F.; Prophylactic treatment with simvastatin modulates the immune response and increases animal survival following lethal sepsis infection. Front Immunol 2018,9,2137","journal-title":"Front Immunol"},{"key":"ref=20","author":"Kaminska M.","year":"2018","unstructured":"Kaminska M.; Aliko A.; Hellvard A.; Bielecka E.; Binder V.; Marczyk A.; Potempa J.; Delaleu N.; Kantyka T.; Mydel P.; Effects of statins on multispecies oral biofilm identify simvastatin as a drug candidate targeting Porphyromonas gingivalis. J Periodontol 2018","journal-title":"J Periodontol"},{"key":"ref=21","author":"Parihar S.P.","year":"2018","unstructured":"Parihar S.P.; Guler R.; Brombacher F.; Statins: A viable candidate for host-directed therapy against infectious diseases. Nat Rev Immunol 2018","journal-title":"Nat Rev Immunol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.2174\/1389201011208062456","volume":"13","author":"Spychalowicz A.","year":"2012","unstructured":"Spychalowicz A.; Wilk G.; \u015aliwa T.; Ludew D.; Guzik T.J.; Novel therapeutic approaches in limiting oxidative stress and inflammation. Curr Pharm Biotechnol 2012,13(13),2456-2466","journal-title":"Curr Pharm Biotechnol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"886","DOI":"10.2174\/1389201017666160301122330","volume":"17","author":"Smelser L.K.","year":"2016","unstructured":"Smelser L.K.; Walker C.; Burns E.M.; Curry M.; Black N.; Metzler J.A.; McDowell S.A.; Bruns H.A.; Short term, low dose simvastatin pretreatment alters memory immune function following secondary Staphylococcus aureus infection. Curr Pharm Biotechnol 2016,17(10),886-893","journal-title":"Curr Pharm Biotechnol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.2174\/138920111798281027","volume":"12","author":"McDowell S.A.","year":"2011","unstructured":"McDowell S.A.; Ma Y.; Kusano R.; Akinbi H.T.; Simvastatin is protective during Staphylococcus aureus pneumonia. Curr Pharm Biotechnol 2011,12(9),1455-1462","journal-title":"Curr Pharm Biotechnol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"396","DOI":"10.2174\/138920111794480570","volume":"12","author":"Ansquer J.C.","year":"2011","unstructured":"Ansquer J.C.; Crimet D.; Foucher C.; Fibrates and statins in the treatment of diabetic retinopathy. Curr Pharm Biotechnol 2011,12(3),396-405","journal-title":"Curr Pharm Biotechnol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"5835","DOI":"10.2174\/0929867325666180327095441","volume":"25","author":"Licata A.","year":"2018","unstructured":"Licata A.; Giammanco A.; Minissale M.G.; Pagano S.; Petta S.; Averna M.; Liver and statins: A critical appraisal of the evidence. Curr Med Chem 2018,25(42),5835-5846","journal-title":"Curr Med Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00253-002-0932-9","volume":"58","author":"Manzoni M.","year":"2002","unstructured":"Manzoni M.; Rollini M.; Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs. Appl Microbiol Biotechnol 2002,58(5),555-564","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"422","DOI":"10.2174\/1389201015666140528152138","volume":"15","author":"Javed S.","year":"2014","unstructured":"Javed S.; Bukhari S.A.; Zovia I.; Meraj M.; Screening of indigenously isolated fungi for lovastatin production and its in vivo evaluation. Curr Pharm Biotechnol 2014,15(4),422-427","journal-title":"Curr Pharm Biotechnol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.7164\/antibiotics.39.1609","volume":"39","author":"Endo A.","year":"1986","unstructured":"Endo A.; Hasumi K.; Yamada A.; Shimoda R.; Takeshima H.; The synthesis of compactin (ML-236B) and monacolin K in fungi. J Antibiot (Tokyo) 1986,39(11),1609-1610","journal-title":"J Antibiot (Tokyo)"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1001\/jama.295.13.jpc60002","volume":"295","author":"Nissen S.E.","year":"2006","unstructured":"Nissen S.E.; Nicholls S.J.; Sipahi I.; Libby P.; Raichlen J.S.; Ballantyne C.M.; Davignon J.; Erbel R.; Fruchart J.C.; Tardif J.C.; Schoenhagen P.; Crowe T.; Cain V.; Wolski K.; Goormastic M.; Tuzcu E.M.; Investigators A.; Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: The ASTEROID trial. JAMA 2006,295(13),1556-1565","journal-title":"JAMA"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"463","DOI":"10.2165\/00003088-200847070-00003","volume":"47","author":"Neuvonen P.J.","year":"2008","unstructured":"Neuvonen P.J.; Backman J.T.; Niemi M.; Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin. Clin Pharmacokinet 2008,47(7),463-474","journal-title":"Clin Pharmacokinet"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.7164\/antibiotics.29.1346","volume":"29","author":"Endo A.","year":"1976","unstructured":"Endo A.; Kuroda M.; Tsujita Y.; ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium. J Antibiot (Tokyo) 1976,29(12),1346-1348","journal-title":"J Antibiot (Tokyo)"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00253-008-1409-2","volume":"79","author":"Barrios-Gonz\u00e1lez J.","year":"2008","unstructured":"Barrios-Gonz\u00e1lez J.; Ba\u00f1os J.G.; Covarrubias A.A.; Garay-Arroyo A.; Lovastatin biosynthetic genes of Aspergillus terreus are expressed differentially in solid-state and in liquid submerged fermentation. Appl Microbiol Biotechnol 2008,79(2),179-186","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"852","DOI":"10.7164\/antibiotics.32.852","volume":"32","author":"Endo A.","year":"1979","unstructured":"Endo A.; Monacolin K.; Monacolin K, a new hypocholesterolemic agent produced by a Monascus species. J Antibiot (Tokyo) 1979,32(8),852-854","journal-title":"J Antibiot (Tokyo)"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.ijbiomac.2017.11.074","volume":"109","author":"Huang J.","year":"2018","unstructured":"Huang J.; Liao N.; Li H.; Linoleic acid enhance the production of moncolin K and red pigments in Monascus ruber by activating mokH and mokA, and by accelerating cAMP-PkA pathway. Int J Biol Macromol 2018,109,950-954","journal-title":"Int J Biol Macromol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.7164\/antibiotics.43.1621","volume":"43","author":"Kimura K.","year":"1990","unstructured":"Kimura K.; Komagata D.; Murakawa S.; Endo A.; Biosynthesis of monacolins: Conversion of monacolin J to monacolin K (mevinolin). J Antibiot (Tokyo) 1990,43(12),1621-1622","journal-title":"J Antibiot (Tokyo)"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1073\/pnas.1419028112","volume":"112","author":"McLean K.J.","year":"2015","unstructured":"McLean K.J.; Hans M.; Meijrink B.; van Scheppingen W.B.; Vollebregt A.; Tee K.L.; van der Laan J.M.; Leys D.; Munro A.W.; van den Berg M.A.; Single-step fermentative production of the cholesterol-lowering drug pravastatin via reprogramming of Penicillium chrysogenum. Proc Natl Acad Sci USA 2015,112(9),2847-2852","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrd1112","volume":"2","author":"Tobert J.A.","year":"2003","unstructured":"Tobert J.A.; Lovastatin and beyond: The history of the HMG-CoA reductase inhibitors. Nat Rev Drug Discov 2003,2(7),517-526","journal-title":"Nat Rev Drug Discov"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1432-1033.1977.tb11637.x","volume":"77","author":"Endo A.","year":"1977","unstructured":"Endo A.; Tsujita Y.; Kuroda M.; Tanzawa K.; Inhibition of cholesterol synthesis in vitro and in vivo by ML-236A and ML-236B, competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Eur J Biochem 1977,77(1),31-36","journal-title":"Eur J Biochem"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0021-9258(17)38120-6","volume":"253","author":"Brown M.S.","year":"1978","unstructured":"Brown M.S.; Faust J.R.; Goldstein J.L.; Kaneko I.; Endo A.; Induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts incubated with compactin (ML-236B), a competitive inhibitor of the reductase. J Biol Chem 1978,253(4),1121-1128","journal-title":"J Biol Chem"},{"year":"1982","author":"Terahara A.","unstructured":"Terahara A.; Tanaka M.; ML-236B Derivatives and their preparation. U.S. Patent 4346227A1982","key":"ref=41"},{"key":"ref=42","first-page":"1","volume":"40","author":"Arai M.","year":"1988","unstructured":"Arai M.; Pravastatin sodium (CS-154), a novel cholesterol-lowering agent which inhibits HMG-CoA reductase. Sankyo Kenkyusyo Nempo 1988,40,1-38","journal-title":"Sankyo Kenkyusyo Nempo"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/0021-9150(82)90070-3","volume":"41","author":"Tobert J.A.","year":"1982","unstructured":"Tobert J.A.; Hitzenberger G.; Kukovetz W.R.; Holmes I.B.; Jones K.H.; Rapid and substantial lowering of human serum cholesterol by mevinolin (MK-803), an inhibitor of hydroxymethylglutaryl-coenzyme A reductase. Atherosclerosis 1982,41(1),61-65","journal-title":"Atherosclerosis"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1073\/pnas.80.13.4124","volume":"96","author":"Bilheimer D.W.","year":"1983","unstructured":"Bilheimer D.W.; Grundy S.M.; Brown M.S.; Goldstein J.L.; Mevinolin stimulates receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes. Trans Assoc Am Physicians 1983,96,1-9","journal-title":"Trans Assoc Am Physicians"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1172\/JCI111618","volume":"74","author":"Illingworth D.R.","year":"1984","unstructured":"Illingworth D.R.; Sexton G.J.; Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia. J Clin Invest 1984,74(6),1972-1978","journal-title":"J Clin Invest"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1592\/phco.25.2.228.56954","volume":"25","author":"Gonyeau M.J.","year":"2005","unstructured":"Gonyeau M.J.; Statins and osteoporosis: A clinical review. Pharmacotherapy 2005,25(2),228-243","journal-title":"Pharmacotherapy"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/nrneurol.2011.165","volume":"7","author":"Sparks D.L.","year":"2011","unstructured":"Sparks D.L.; Alzheimer disease: statins in the treatment of Alzheimer disease. Nat Rev Neurol 2011,7(12),662-663","journal-title":"Nat Rev Neurol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1634\/theoncologist.11-3-306","volume":"11","author":"Hindler K.","year":"2006","unstructured":"Hindler K.; Cleeland C.S.; Rivera E.; Collard C.D.; The role of statins in cancer therapy. Oncologist 2006,11(3),306-315","journal-title":"Oncologist"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1615\/IntJMedMushrooms.v17.i2.30","volume":"17","author":"Lam Y.S.","year":"2015","unstructured":"Lam Y.S.; Okello E.J.; Determination of lovastatin, \u03b2-glucan, total polyphenols, and antioxidant activity in raw and processed oyster culinary-medicinal mushroom, Pleurotus ostreatus (Higher Basidiomycetes). Int J Med Mushrooms 2015,17(2),117-128","journal-title":"Int J Med Mushrooms"},{"key":"ref=50","first-page":"319","volume":"34","author":"Pattanagul P.","year":"2007","unstructured":"Pattanagul P.; Pinthong R.; Phianmongkhol A.; Leksawasdi N.; Review of angkak production (Monascus purpureus). Warasan Khana Witthayasat Maha Witthayalai Chiang Mai 2007,34(3),319-328","journal-title":"Warasan Khana Witthayasat Maha Witthayalai Chiang Mai"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ijfoodmicro.2008.04.019","volume":"126","author":"Pattanagul P.","year":"2008","unstructured":"Pattanagul P.; Pinthong R.; Phianmongkhol A.; Tharatha S.; Mevinolin, citrinin and pigments of adlay angkak fermented by Monascus sp. Int J Food Microbiol 2008,126(1-2),20-23","journal-title":"Int J Food Microbiol"},{"key":"ref=52","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcab.2017.04.011","author":"Rahim M.H.A.","year":"2017","unstructured":"Rahim M.H.A.; Harith H.H.; Montoya A.; Abbas A.; Growth and lovastatin production by Aspergillus terreus under different carbohyrates as carbon sources. Biocatal Agric Biotechnol 2017","journal-title":"Biocatal Agric Biotechnol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/10_2014_302","volume":"149","author":"Bizukojc M.","year":"2015","unstructured":"Bizukojc M.; Ledakowicz S.; Bioprocess engineering aspects of the cultivation of a lovastatin producer Aspergillus terreus. Adv Biochem Eng Biotechnol 2015,149,133-170","journal-title":"Adv Biochem Eng Biotechnol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1515\/znc-2006-1-217","volume":"61","author":"Alarc\u00f3n J.","year":"2006","unstructured":"Alarc\u00f3n J.; Aguila S.; Lovastatin production by Pleurotus ostreatus: Effects of the C:N ratio. Z Natforsch C J Biosci 2006,61(1-2),95-98","journal-title":"Z Natforsch C J Biosci"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.riam.2014.06.008","volume":"32","author":"Atl\u0131 B.","year":"2015","unstructured":"Atl\u0131 B.; Yama\u00e7 M.; Y\u0131ld\u0131z Z.; Isikhuemnen O.S.; Enhanced production of lovastatin by Omphalotus olearius (DC.) Singer in solid state fermentation. Rev Iberoam Micol 2015,32(4),247-251","journal-title":"Rev Iberoam Micol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1615\/IntJMedMushr.v14.i2.30","volume":"14","author":"Atli B.","year":"2012","unstructured":"Atli B.; Yamac M.; Screening of medicinal higher Basidiomycetes mushrooms from Turkey for lovastatin production. Int J Med Mushrooms 2012,14(2),149-159","journal-title":"Int J Med Mushrooms"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1007\/s12010-009-8762-1","volume":"160","author":"Jia Z.","year":"2010","unstructured":"Jia Z.; Zhang X.; Zhao Y.; Cao X.; Enhancement of lovastatin production by supplementing polyketide antibiotics to the submerged culture of Aspergillus terreus. Appl Biochem Biotechnol 2010,160(7),2014-2025","journal-title":"Appl Biochem Biotechnol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S0032-9592(00)00222-3","volume":"36","author":"Kumar M.S.","year":"2000","unstructured":"Kumar M.S.; Jana S.K.; Senthil V.; Shashanka V.; Kumar S.V.K.; S.A., Repeated fed-batch process for improving lovastatin production. Process Biochem 2000,36(4),363-368","journal-title":"Process Biochem"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S1074-5521(99)80061-1","volume":"6","author":"Hendrickson L.","year":"1999","unstructured":"Hendrickson L.; Davis C.R.; Roach C.; Nguyen D.K.; Aldrich T.; McAda P.C.; Reeves C.D.; Lovastatin biosynthesis in Aspergillus terreus: Characterization of blocked mutants, enzyme activities and a multifunctional polyketide synthase gene. Chem Biol 1999,6(7),429-439","journal-title":"Chem Biol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1126\/science.284.5418.1368","volume":"284","author":"Kennedy J.","year":"1999","unstructured":"Kennedy J.; Auclair K.; Kendrew S.G.; Park C.; Vederas J.C.; Hutchinson C.R.; Modulation of polyketide synthase activity by accessory proteins during lovastatin biosynthesis. Science 1999,284(5418),1368-1372","journal-title":"Science"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"8078","DOI":"10.1021\/ja201138v","volume":"133","author":"Barriuso J.","year":"2011","unstructured":"Barriuso J.; Nguyen D.T.; Li J.W.; Roberts J.N.; MacNevin G.; Chaytor J.L.; Marcus S.L.; Vederas J.C.; Ro D.K.; Double oxidation of the cyclic nonaketide dihydromonacolin L to monacolin J by a single cytochrome P450 monooxygenase, LovA. J Am Chem Soc 2011,133(21),8078-8081","journal-title":"J Am Chem Soc"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jbiosc.2009.03.006","volume":"108","author":"Ba\u00f1os J.G.","year":"2009","unstructured":"Ba\u00f1os J.G.; Tomasini A.; Szak\u00e1cs G.; Barrios-Gonz\u00e1lez J.; High lovastatin production by Aspergillus terreus in solid-state fermentation on polyurethane foam: An artificial inert support. J Biosci Bioeng 2009,108(2),105-110","journal-title":"J Biosci Bioeng"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"6472","DOI":"10.1002\/anie.201302406","volume":"52","author":"Xu W.","year":"2013","unstructured":"Xu W.; Chooi Y.H.; Choi J.W.; Li S.; Vederas J.C.; Da Silva N.A.; Tang Y.; Lov G.; LovG: the thioesterase required for dihydromonacolin L release and lovastatin nonaketide synthase turnover in lovastatin biosynthesis. Angew Chem Int Ed Engl 2013,52(25),6472-6475","journal-title":"Angew Chem Int Ed Engl"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.chembiol.2009.09.017","volume":"16","author":"Gao X.","year":"2009","unstructured":"Gao X.; Xie X.; Pashkov I.; Sawaya M.R.; Laidman J.; Zhang W.; Cacho R.; Yeates T.O.; Tang Y.; Directed evolution and structural characterization of a simvastatin synthase. Chem Biol 2009,16(10),1064-1074","journal-title":"Chem Biol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1039\/b207721c","volume":"1","author":"Sorensen J.L.","year":"2003","unstructured":"Sorensen J.L.; Auclair K.; Kennedy J.; Hutchinson C.R.; Vederas J.C.; Transformations of cyclic nonaketides by Aspergillus terreus mutants blocked for lovastatin biosynthesis at the lovA and lovC genes. Org Biomol Chem 2003,1(1),50-59","journal-title":"Org Biomol Chem"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s00284-017-1353-4","volume":"75","author":"Bhargavi S.D.","year":"2018","unstructured":"Bhargavi S.D.; Praveen V.K.; Anil Kumar M.; Savitha J.; Comparative study on whole genome sequences of Aspergillus terreus (soil fungus) and Diaporthe ampelina (endophytic fungus) with reference to lovastatin production. Curr Microbiol 2018,75(1),84-91","journal-title":"Curr Microbiol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.funbio.2014.09.002","volume":"118","author":"Miranda R.U.","year":"2014","unstructured":"Miranda R.U.; G\u00f3mez-Quiroz L.E.; Mendoza M.; P\u00e9rez-S\u00e1nchez A.; Fierro F.; Barrios-Gonz\u00e1lez J.; Reactive oxygen species regulate lovastatin biosynthesis in Aspergillus terreus during submerged and solid-state fermentations. Fungal Biol 2014,118(12),979-989","journal-title":"Fungal Biol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.chembiol.2006.09.008","volume":"13","author":"Xie X.","year":"2006","unstructured":"Xie X.; Watanabe K.; Wojcicki W.A.; Wang C.C.; Tang Y.; Biosynthesis of lovastatin analogs with a broadly specific acyltransferase. Chem Biol 2006,13(11),1161-1169","journal-title":"Chem Biol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1128\/AEM.02820-06","volume":"73","author":"Xie X.","year":"2007","unstructured":"Xie X.; Tang Y.; Efficient synthesis of simvastatin by use of whole-cell biocatalysis. Appl Environ Microbiol 2007,73(7),2054-2060","journal-title":"Appl Environ Microbiol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nchembio.1503","volume":"10","author":"Jim\u00e9nez-Os\u00e9s G.","year":"2014","unstructured":"Jim\u00e9nez-Os\u00e9s G.; Osuna S.; Gao X.; Sawaya M.R.; Gilson L.; Collier S.J.; Huisman G.W.; Yeates T.O.; Tang Y.; Houk K.N.; The role of distant mutations and allosteric regulation on LovD active site dynamics. Nat Chem Biol 2014,10(6),431-436","journal-title":"Nat Chem Biol"},{"key":"ref=71","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00253-009-2239-6","volume":"85","author":"Vinci V.A.","year":"2010","unstructured":"Vinci V.A.; Hoerner T.D.; Coffman A.D.; Schimmel T.G.; Dabora R.L.; Kirpekal A.C.; Ruby C.L.; Stieber R.W.; Mutants of a lovastatin-hyperproducing Aspergillus terreus deficient in the production of sulochrin. Appl Microbiol Biotechnol 2010,85,869-883","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.bej.2008.06.022","volume":"42","author":"Bizukojc M.","year":"2008","unstructured":"Bizukojc M.; Ledakowicz S.; Biosynthesis of lovastatin and (+)-geodin by Aspergillus terreus in batch and fed-batch culture in the stirred tank bioreactor. Biochem Eng J 2008,42(3),198-207","journal-title":"Biochem Eng J"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/biot.200800289","volume":"4","author":"Bizukojc M.","year":"2009","unstructured":"Bizukojc M.; Ledakowicz S.; Physiological, morphological and kinetic aspects of lovastatin biosynthesis by Aspergillus terreus. Biotechnol J 2009,4(5),647-664","journal-title":"Biotechnol J"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/S0141-0229(03)00130-3","volume":"33","author":"L\u00f3pez J.L.C.","year":"2003","unstructured":"L\u00f3pez J.L.C.; P\u00e9rez J.A.S.; Sevilla J.M.F.; Fern\u00e1ndez F.G.A.; Grimaa Y.; Chisti E.M.; Production of lovastatin by Aspergillus terreus: effects of the C:N ratio and the principal nutrients on growth and metabolite production. Enzyme Microb Technol 2003,33(2-3),270-277","journal-title":"Enzyme Microb Technol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s00449-015-1366-y","volume":"38","author":"Bizukojc M.","year":"2015","unstructured":"Bizukojc M.; Gonciarz J.; Influence of oxygen on lovastatin biosynthesis by Aspergillus terreus ATCC 20542 quantitatively studied on the level of individual pellets. Bioprocess Biosyst Eng 2015,38(7),1251-1266","journal-title":"Bioprocess Biosyst Eng"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jbiotec.2018.01.010","volume":"269","author":"Arora S.","year":"2018","unstructured":"Arora S.; Rani R.; Ghosh S.; Bioreactors in solid state fermentation technology: Design, applications and engineering aspects. J Biotechnol 2018,269,16-34","journal-title":"J Biotechnol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.biotechadv.2015.04.001","volume":"33","author":"Mulder K.C.","year":"2015","unstructured":"Mulder K.C.; Mulinari F.; Franco O.L.; Soares M.S.; Magalh\u00e3es B.S.; Parachin N.S.; Lovastatin production: From molecular basis to industrial process optimization. Biotechnol Adv 2015,33(6 Pt 1),648-665","journal-title":"Biotechnol Adv"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jbiotec.2015.04.011","volume":"206","author":"Zhang B.B.","year":"2015","unstructured":"Zhang B.B.; Lu L.P.; Xu G.R.; Why solid-state fermentation is more advantageous over submerged fermentation for converting high concentration of glycerol into Monacolin K by Monascus purpureus 9901: A mechanistic study. J Biotechnol 2015,206,60-65","journal-title":"J Biotechnol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lwt.2018.02.013","volume":"92","author":"Suraiya S.","year":"2018","unstructured":"Suraiya S.; Kim J-H.; Tak J.Y.; Siddique M.P.; Young C.J.; Kim J.K.; Kong I-S.; Influences of fermentation parameters on lovastatin production by Monascus purpureus using Saccharina japonica as solid fermented substrate. LWT 2018,92,1-9","journal-title":"LWT"},{"key":"ref=80","first-page":"75","volume":"3","author":"Reddy D.S.","year":"2011","unstructured":"Reddy D.S.; Latha D.P.; Latha K.P.J.H.; Poduction of lovastatin by solid state fermentation by Penicillium funiculosum NCM 1174. Drug Invention Today 2011,3(6),75-77","journal-title":"Drug Invention Today"},{"key":"ref=81","first-page":"9","volume":"1","author":"Chanakya P.","year":"2011","unstructured":"Chanakya P.; Latha P.M.; Srikanth M.; Solid state fermentation for the production of lovastatin by Aspergillus fischerii. Res J Pharma Sci Bioctechnol 2011,1(1),9-13","journal-title":"Res J Pharma Sci Bioctechnol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00253-010-2722-0","volume":"88","author":"Sorrentino F.","year":"2010","unstructured":"Sorrentino F.; Roy I.; Keshavarz T.; Impact of linoleic acid supplementation on lovastatin production in Aspergillus terreus cultures. Appl Microbiol Biotechnol 2010,88(1),65-73","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=83","first-page":"718","volume":"5","author":"Osman M.E.","year":"2011","unstructured":"Osman M.E.; Khattab O.H.; Zghlol G.M.; El-Hameed R.M.; Optimization of some physical and chemical factors for lovastatin productivity by local strain of Aspergillus terreus. Aust J Basic Appl Sci 2011,5(6),718-732","journal-title":"Aust J Basic Appl Sci"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jbiotec.2010.10.079","volume":"151","author":"Pecyna M.","year":"2011","unstructured":"Pecyna M.; Bizukojc M.; Lovastatin biosynthesis by Aspergillus terreus with the simultaneous use of lactose and glycerol in a discontinuous fed-batch culture. J Biotechnol 2011,151(1),77-86","journal-title":"J Biotechnol"},{"key":"ref=85","first-page":"29","volume":"7","author":"Samiee S.M.","year":"2001","unstructured":"Samiee S.M.; Moazami N.; Haghighui S.; Mohseni F.A.; Mirdamadi S.; Bakhtiari M.R.; Screening of lovastatin production by filamentous fungi. Iran Biomed J 2001,7(1),29-33","journal-title":"Iran Biomed J"},{"key":"ref=86","first-page":"2730","volume":"2","author":"Jaivel N.","year":"2010","unstructured":"Jaivel N.; Marimuthu P.; Optimization of lovastatin production in solid state fermentation by Aspergillus terreus. Int J Eng Sci Technol 2010,2(7),2730-2733","journal-title":"Int J Eng Sci Technol"},{"key":"ref=87","first-page":"1","volume":"27","author":"Prabhakar M.","year":"2011","unstructured":"Prabhakar M.; Lingappa K.; Vivek B.; Amena S.; Vishalakshi N.; Mahesh D.; Characterization of physical factors for optimum lovastatin production by Aspergillus terreus KLVB28mu21 under solid state fermentation. J Recent Adv Appl Sci 2011,27,1-5","journal-title":"J Recent Adv Appl Sci"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1631\/jzus.2007.A1521","volume":"8","author":"Pie-Lien W.","year":"2007","unstructured":"Pie-Lien W.; Zhi-nan X.C.P.; Lovastatin production by Aspergillus terreus in solid-state fermentation. J Zhejiang Univ Sci 2007,8(9),1521-1526","journal-title":"J Zhejiang Univ Sci"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1590\/S1517-838220100001000024","volume":"41","author":"Pansuriya R.C.","year":"2010","unstructured":"Pansuriya R.C.; Singhal R.S.; Response surface methodology for optimization of production of lovastatin by solid state fermentation. Braz J Microbiol 2010,41(1),164-172","journal-title":"Braz J Microbiol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.enzmictec.2005.03.009","volume":"37","author":"Valera H.R.","year":"2005","unstructured":"Valera H.R.; Gomes J.; Lakshmi S.; Gururaja R.; Suryanarayan S.; Kumar D.; Lovastatin production by solid state fermentation using Aspergillus flavipes. Enzyme Microb Technol 2005,37(5),521-526","journal-title":"Enzyme Microb Technol"},{"key":"ref=91","first-page":"633","volume":"39","author":"Trenin A.S.","year":"2013","unstructured":"Trenin A.S.; Microbial metabolites that inhibit sterol biosynthesis, their chemical diversity and characteristics of mode of action. Bioorg Khim 2013,39(6),633-657","journal-title":"Bioorg Khim"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2174\/138920101703160206151242","volume":"17","author":"Javed S.","year":"2016","unstructured":"Javed S.; Bukhari S.A.; Ali M.; Sajjad-ur-Rehman. Estimation of antifungal activity of mevastatin produced by Aspergillus terreus GCBL-03 on pretreated substrate in solid state fermentation. Curr Pharm Biotechnol 2016,17(3),291-298","journal-title":"Curr Pharm Biotechnol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1007\/s00253-006-0577-1","volume":"73","author":"Sayyad S.A.","year":"2007","unstructured":"Sayyad S.A.; Panda B.P.; Javed S.; Ali M.; Optimization of nutrient parameters for lovastatin production by Monascus purpureus MTCC 369 under submerged fermentation using response surface methodology. Appl Microbiol Biotechnol 2007,73(5),1054-1058","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.fbp.2010.01.006","volume":"88","author":"Seraman S.","year":"2010","unstructured":"Seraman S.; Aravindan R.; Viruthagi T.; Statistical optimization of anticholesterolemic drug lovastatin production by the red mold Monascus purpureus. Food Bioprod Process 2010,88(2-3),266-276","journal-title":"Food Bioprod Process"},{"key":"ref=95","doi-asserted-by":"crossref","first-page":"116","DOI":"10.11648\/j.ajhr.20150302.19","volume":"3","author":"Praveen V.K.","year":"2015","unstructured":"Praveen V.K.; Bhargavi S.D.; Savitha J.; Lovastatin production by Aspergillus terreus (KM017963) in submerged and solid state fermentation: A comparative study. Amer J Pharmacol Health Res 2015,3(7),116-126","journal-title":"Amer J Pharmacol Health Res"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.bej.2016.01.017","volume":"109","author":"Gonciarz J.","year":"2016","unstructured":"Gonciarz J.; Kowalska A.; Bizukojc M.; Application of microparticle-enhanced cultivation to increase the access of oxygen to Aspergillus terreus ATCC 20542 mycelium and intensify lovastatin biosynthesis in batch and continuous fed-batch stirred tank bioreactors. Biochem Eng J 2016,109,178-188","journal-title":"Biochem Eng J"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.funbio.2012.12.001","volume":"117","author":"Miranda R.U.","year":"2013","unstructured":"Miranda R.U.; G\u00f3mez-Quiroz L.E.; Mej\u00eda A.; Barrios-Gonz\u00e1lez J.; Oxidative state in idiophase links Reactive Oxygen Species (ROS) and lovastatin biosynthesis: Differences and similarities in submerged- and solid-state fermentations. Fungal Biol 2013,117(2),85-93","journal-title":"Fungal Biol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"7347","DOI":"10.1007\/s00253-017-8452-9","volume":"101","author":"P\u00e9rez-S\u00e1nchez A.","year":"2017","unstructured":"P\u00e9rez-S\u00e1nchez A.; Uribe-Carvajal S.; Cabrera-Orefice A.; Barrios-Gonz\u00e1lez J.; Key role of alternative oxidase in lovastatin solid-state fermentation. Appl Microbiol Biotechnol 2017,101(19),7347-7356","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=99","first-page":"78","volume":"10","author":"Xu B.","year":"2005","unstructured":"Xu B.; Wang Q.; Jia X.; Sung C.; Enhanced lovastatin production by solid state fermentation of Monascus ruber. Biotechnology Biochem Eng 2005,10,78-84","journal-title":"Biotechnology Biochem Eng"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jgeb.2016.10.006","volume":"14","author":"Mouafi F.E.","year":"2016","unstructured":"Mouafi F.E.; Ibrahim G.S.; Abo Elsoud M.M.; Optimization of lovastatin production from Aspergillus fumigatus. J Genet Eng Biotechnol 2016,14(2),253-259","journal-title":"J Genet Eng Biotechnol"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jbiotec.2012.09.007","volume":"162","author":"Bizukojc M.","year":"2012","unstructured":"Bizukojc M.; Pawlak M.; Boruta T.; Gonciarz J.; Effect of pH on biosynthesis of lovastatin and other secondary metabolites by Aspergillus terreus ATCC 20542. J Biotechnol 2012,162(2-3),253-261","journal-title":"J Biotechnol"},{"key":"ref=102","first-page":"375","volume":"Vol.18","author":"P.A. Belter","year":"1988","unstructured":"P.A. Belter; E.L. Cussler; and W.S. Hu; A Review of: \u201cBioseparations\u201d Downstream Processing for Biotechnology 1988,Vol.18(3),375-376","journal-title":"Downstream Processing for Biotechnology"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.seppur.2011.12.020","volume":"88","author":"Martins S.","year":"2012","unstructured":"Martins S.; Aguilar C.N.; Teixeira J.A.; Mussatto S.I.; Bioactive compounds (phytoestrogens) recovery from Larrea tridentata leaves by solvents extraction. Separ Purif Tech 2012,88,163-167","journal-title":"Separ Purif Tech"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.seppur.2012.06.006","volume":"96","author":"Lisec B.","year":"2012","unstructured":"Lisec B.; Radez I.; Zilnik L.F.; Solvent extraction of lovastatin from a fermentation broth. Separ Purif Tech 2012,96,187-193","journal-title":"Separ Purif Tech"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.1073\/pnas.77.7.3957","volume":"77","author":"Alberts A.W.","year":"1980","unstructured":"Alberts A.W.; Chen J.; Kuron G.; Hunt V.; Huff J.; Hoffman C.; Rothrock J.; Lopez M.; Joshua H.; Harris E.; Patchett A.; Monaghan R.; Currie S.; Stapley E.; Albers-Schonberg G.; Hensens O.; Hirshfield J.; Hoogsteen K.; Liesch J.; Springer J.; Mevinolin: A highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent. Proc Natl Acad Sci USA 1980,77(7),3957-3961","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"334","DOI":"10.7164\/antibiotics.33.334","volume":"33","author":"Endo A.","year":"1980","unstructured":"Endo A.; Monacolin K.; Monacolin K, a new hypocholesterolemic agent that specifically inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase. J Antibiot (Tokyo) 1980,33(3),334-336","journal-title":"J Antibiot (Tokyo)"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1128\/AEM.67.6.2596-2602.2001","volume":"67","author":"Hajjaj H.","year":"2001","unstructured":"Hajjaj H.; Niederberger P.; Duboc P.; Lovastatin biosynthesis by Aspergillus terreus in a chemically defined medium. Appl Environ Microbiol 2001,67(6),2596-2602","journal-title":"Appl Environ Microbiol"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1021\/jm00155a040","volume":"29","author":"Hoffman W.F.","year":"1986","unstructured":"Hoffman W.F.; Alberts A.W.; Anderson P.S.; Chen J.S.; Smith R.L.; Willard A.K.; 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor. 4. Side chain ester derivatives of mevinolin. J Med Chem 1986,29(5),849-852","journal-title":"J Med Chem"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ymben.2017.06.005","volume":"42","author":"Huang X.","year":"2017","unstructured":"Huang X.; Liang Y.; Yang Y.; Lu X.; Single-step production of the simvastatin precursor monacolin J by engineering of an industrial strain of Aspergillus terreus. Metab Eng 2017,42,109-114","journal-title":"Metab Eng"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1365-2710.2009.01085.x","volume":"35","author":"Weng T.C.","year":"2010","unstructured":"Weng T.C.; Yang Y.H.; Lin S.J.; Tai S.H.; A systematic review and meta-analysis on the therapeutic equivalence of statins. J Clin Pharm Ther 2010,35(2),139-151","journal-title":"J Clin Pharm Ther"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.btre.2015.04.002","volume":"6","author":"Syed M.B.","year":"2015","unstructured":"Syed M.B.; Rajasimman M.; Fermentative production and optimization of mevastatin in submerged fermentation using Aspergillus terreus. Biotechnol Rep (Amst) 2015,6,124-128","journal-title":"Biotechnol Rep (Amst)"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1023\/A:1023237510458","volume":"26","author":"Hatanaka T.","year":"1998","unstructured":"Hatanaka T.; Honda S.; Sasaki S.; Katayama K.; Koizumi T.; Pharmacokinetic and pharmacodynamic evaluation for tissue-selective inhibition of cholesterol synthesis by pravastatin. J Pharmacokinet Biopharm 1998,26(3),329-347","journal-title":"J Pharmacokinet Biopharm"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1007\/BF03216285","volume":"40","author":"Ditschuneit H.H.","year":"1991","unstructured":"Ditschuneit H.H.; Kuhn K.; Ditschuneit H.; Comparison of different HMG-CoA reductase inhibitors. Eur J Clin Pharmacol 1991,40(Suppl. 1),S27-S32","journal-title":"Eur J Clin Pharmacol"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s00253-009-2239-6","volume":"85","author":"Barrios-Gonz\u00e1lez J.","year":"2010","unstructured":"Barrios-Gonz\u00e1lez J.; Miranda R.U.; Biotechnological production and applications of statins. Appl Microbiol Biotechnol 2010,85(4),869-883","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=115","author":"Seydametova E.","year":"2013","unstructured":"Seydametova E.; Production of pravastatin by filamentous fungi isolated from soil 2013","journal-title":"Production of pravastatin by filamentous fungi isolated from soil"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"80","DOI":"10.17706\/ijbbb.2015.5.2.80-90","volume":"5","author":"Seydametova E.","year":"2015","unstructured":"Seydametova E.; Novel pravastatin-producing Penicillium janthinellum strain isolated from soil. Int J Biosci Biochem Bioinform 2015,5(2),80","journal-title":"Int J Biosci Biochem Bioinform"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/bit.260420705","volume":"42","author":"Hosobuchi M.","year":"1993","unstructured":"Hosobuchi M.; Kurosawa K.; Yoshikawa H.; Application of computer to monitoring and control of fermentation process: Microbial conversion of ML-236B Na to pravastatin. Biotechnol Bioeng 1993,42(7),815-820","journal-title":"Biotechnol Bioeng"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.bcab.2017.11.002","volume":"13","author":"Syed M.B.","year":"2017","unstructured":"Syed M.B.; Ponnusamy T.; Bioconversion of mevastatin to pravastatin by various microorganisms and its application - A review. Biocatal Agric Biotechnol 2017,13,62-74","journal-title":"Biocatal Agric Biotechnol"},{"key":"ref=119","first-page":"690","volume":"19","author":"Shaligram N.S.","year":"2009","unstructured":"Shaligram N.S.; Singh S.K.; Singhal R.S.; Szakacs G.; Pandey A.; Effect of precultural and nutritional parameters on compactin production by solid-state fermentation. J Microbiol Biotechnol 2009,19(7),690-697","journal-title":"J Microbiol Biotechnol"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s12088-015-0537-5","volume":"55","author":"Dzhavakhiya V.V.","year":"2015","unstructured":"Dzhavakhiya V.V.; Voinova T.M.; Glagoleva E.V.; Petukhov D.V.; Ovchinnikov A.I.; Kartashov M.I.; Kuznetsov B.B.; Skryabin K.G.; Strain improvement of Streptomyces xanthochromogenes RIA 1098 for enhanced pravastatin production at high compactin concentrations. Indian J Microbiol 2015,55(4),440-446","journal-title":"Indian J Microbiol"},{"year":"2004","author":"Jekkel A.","unstructured":"Jekkel A.; Konya A.; Barta I.; Ilkoy E.; Somogyi G.; Ambrus G.; Microbial process for pravastatin. US Patent 6,750,366 B22004","key":"ref=121"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"10187","DOI":"10.1016\/j.biortech.2011.09.029","volume":"102","author":"Lin C.L.","year":"2011","unstructured":"Lin C.L.; Tang Y.L.; Lin S.M.; Efficient bioconversion of compactin to pravastatin by the quinoline-degrading microorganism Pseudonocardia carboxydivorans isolated from petroleum-contaminated soil. Bioresour Technol 2011,102(22),10187-10193","journal-title":"Bioresour Technol"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/cid\/cir308","volume":"53","author":"Talan D.A.","year":"2011","unstructured":"Talan D.A.; Krishnadasan A.; Gorwitz R.J.; Fosheim G.E.; Limbago B.; Albrecht V.; Moran G.J.; Group E.M.I.N.S.; Comparison of Staphylococcus aureus from skin and soft-tissue infections in US emergency department patients, 2004 and 2008. Clin Infect Dis 2011,53(2),144-149","journal-title":"Clin Infect Dis"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"11144","DOI":"10.1073\/pnas.1113029109","volume":"109","author":"Ames B.D.","year":"2012","unstructured":"Ames B.D.; Nguyen C.; Bruegger J.; Smith P.; Xu W.; Ma S.; Wong E.; Wong S.; Xie X.; Li J.W.; Vederas J.C.; Tang Y.; Tsai S.C.; Crystal structure and biochemical studies of the trans-acting polyketide enoyl reductase LovC from lovastatin biosynthesis. Proc Natl Acad Sci USA 2012,109(28),11144-11149","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s12013-014-9914-7","volume":"70","author":"Mukhtar H.","year":"2014","unstructured":"Mukhtar H.; Ijaz S.S.; Ikram-ul-Haq. Upstream and downstream processing of lovastatin by Aspergillus terreus. Cell Biochem Biophys 2014,70(1),309-320","journal-title":"Cell Biochem Biophys"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1556\/AMicr.56.2009.2.5","volume":"56","author":"Kaur H.","year":"2009","unstructured":"Kaur H.; Kaur A.; Saini H.S.; Chadha B.S.; Screening and selection of lovastatin hyper-producing mutants of Aspergillus terreus using cyclic mutagenesis. Acta Microbiol Immunol Hung 2009,56(2),169-180","journal-title":"Acta Microbiol Immunol Hung"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"3953","DOI":"10.1007\/s00253-017-8263-z","volume":"101","author":"El-Sayed A.S.A.","year":"2017","unstructured":"El-Sayed A.S.A.; Abdel-Ghany S.E.; Ali G.S.; Genome editing approaches: Manipulating of lovastatin and taxol synthesis of filamentous fungi by CRISPR\/Cas9 system. Appl Microbiol Biotechnol 2017,101(10),3953-3976","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s10529-015-2015-x","volume":"38","author":"Katayama T.","year":"2016","unstructured":"Katayama T.; Tanaka Y.; Okabe T.; Nakamura H.; Fujii W.; Kitamoto K.; Maruyama J.; Development of a genome editing technique using the CRISPR\/Cas9 system in the industrial filamentous fungus Aspergillus oryzae. Biotechnol Lett 2016,38(4),637-642","journal-title":"Biotechnol Lett"},{"key":"ref=129","first-page":"478","volume":"32","author":"Li N.","year":"2016","unstructured":"Li N.; Li M.; Yu Z.; Zhou J.; Huang J.; One-step fermentation for producing simvastatin via RNAi silencing of lovF gene in Aspergillus terreus. Sheng Wu Gong Cheng Xue Bao 2016,32(4),478-486","journal-title":"Sheng Wu Gong Cheng Xue Bao"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"e00603","DOI":"10.1128\/AEM.00603-17","volume":"83","author":"Li M.","year":"2017","unstructured":"Li M.; Zhang Z.J.; Kong X.D.; Yu H.L.; Zhou J.; Xu J.H.; Engineering Streptomyces coeli color carbonyl reductase for efficient atorvastatin precursor synthesis. Appl Environ Microbiol 2017,83(12),e00603-e00617","journal-title":"Appl Environ Microbiol"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.bbrc.2010.12.013","volume":"404","author":"Fujii Y.","year":"2011","unstructured":"Fujii Y.; Norihisa K.; Fujii T.; Aritoku Y.; Kagawa Y.; Sallam K.I.; Johdo O.; Arisawa A.; Tamura T.; Construction of a novel expression vector in Pseudonocardia autotrophica and its application to efficient biotransformation of compactin to pravastatin, a specific HMG-CoA reductase inhibitor. Biochem Biophys Res Commun 2011,404(1),511-516","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s00284-005-0276-7","volume":"53","author":"Chen C.H.","year":"2006","unstructured":"Chen C.H.; Hu H.Y.; Cho Y.C.; Hsu W.H.; Screening of compactin-resistant microorganisms capable of converting compactin to pravastatin. Curr Microbiol 2006,53(2),108-112","journal-title":"Curr Microbiol"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"182","DOI":"10.6026\/97320630011182","volume":"11","author":"Basu S.","year":"2015","unstructured":"Basu S.; Bose C.; Ojha N.; Das N.; Das J.; Pal M.; Khurana S.; Evolution of bacterial and fungal growth media. Bioinformation 2015,11(4),182-184","journal-title":"Bioinformation"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ymben.2007.05.006","volume":"9","author":"Xie X.","year":"2007","unstructured":"Xie X.; Wong W.W.; Tang Y.; Improving simvastatin bioconversion in Escherichia coli by deletion of bioH. Metab Eng 2007,9(4),379-386","journal-title":"Metab Eng"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/bit.22028","volume":"102","author":"Xie X.","year":"2009","unstructured":"Xie X.; Pashkov I.; Gao X.; Guerrero J.L.; Yeates T.O.; Tang Y.; Rational improvement of simvastatin synthase solubility in Escherichia coli leads to higher whole-cell biocatalytic activity. Biotechnol Bioeng 2009,102(1),20-28","journal-title":"Biotechnol Bioeng"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1073\/pnas.80.13.4124","volume":"80","author":"Bilheimer D.W.","year":"1983","unstructured":"Bilheimer D.W.; Grundy S.M.; Brown M.S.; Goldstein J.L.; Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes. Proc Natl Acad Sci USA 1983,80(13),4124-4128","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=137","first-page":"803","volume":"60","author":"Thompson G.R.","year":"1986","unstructured":"Thompson G.R.; Ford J.; Jenkinson M.; Trayner I.; Efficacy of mevinolin as adjuvant therapy for refractory familial hypercholesterolaemia. Q J Med 1986,60(232),803-811","journal-title":"Q J Med"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1001\/archinte.1991.00400010067008","volume":"151","author":"Bradford R.H.","year":"1991","unstructured":"Bradford R.H.; Shear C.L.; Chremos A.N.; Dujovne C.; Downton M.; Franklin F.A.; Gould A.L.; Hesney M.; Higgins J.; Hurley D.P.; Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia. Arch Intern Med 1991,151(1),43-49","journal-title":"Arch Intern Med"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1001\/jama.282.21.2043","volume":"282","author":"Steinberg D.","year":"1999","unstructured":"Steinberg D.; Gotto A.M.; Preventing coronary artery disease by lowering cholesterol levels: Fifty years from bench to bedside. JAMA 1999,282(21),2043-2050","journal-title":"JAMA"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1136\/bmj.304.6824.431","volume":"304","author":"Davey Smith G.","year":"1992","unstructured":"Davey Smith G.; Pekkanen J.; Should there be a moratorium on the use of cholesterol lowering drugs? BMJ 1992,304(6824),431-434","journal-title":"BMJ"},{"key":"ref=141","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1128\/JB.162.2.704-707.1985","volume":"162","author":"Greenspan M.D.","year":"1985","unstructured":"Greenspan M.D.; Yudkovitz J.B.; Mevinolinic acid biosynthesis by Aspergillus terreus and its relationship to fatty acid biosynthesis. J Bacteriol 1985,162(2),704-707","journal-title":"J Bacteriol"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1023\/A:1018322628333","volume":"19","author":"Novak N.","year":"1997","unstructured":"Novak N.; Gerdin S.; Berovic M.; Increased lovastatin formation by Aspergillus terreus using repeated fed-batch process. Biotechnol Lett 1997,19(10),947-948","journal-title":"Biotechnol Lett"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/emyc.1995.1001","volume":"19","author":"Gunde-Cimerman N.","year":"1995","unstructured":"Gunde-Cimerman N.; Cimerman A.; Pleurotus fruiting bodies contain the inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase-lovastatin. Exp Mycol 1995,19(1),1-6","journal-title":"Exp Mycol"},{"key":"ref=144","author":"Serizawa N.","year":"1997","unstructured":"Serizawa N.; Hosobuchi M.; Yoshikawa H.; Biochemical and fermentation technological approaches to production of pravastatin, a HMG-CoA reductase inhibitor 1997","journal-title":"Biochemical and fermentation technological approaches to production of pravastatin, a HMG-CoA reductase inhibitor"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/j.1432-1033.1989.tb15070.x","volume":"184","author":"Matsuoka T.","year":"1989","unstructured":"Matsuoka T.; Miyakoshi S.; Tanzawa K.; Nakahara K.; Hosobuchi M.; Serizawa N.; Purification and characterization of cytochrome P-450sca from Streptomyces carbophilus. ML-236B (compactin) induces a cytochrome P-450sca in Streptomyces carbophilus that hydroxylates ML-236B to pravastatin sodium (CS-514), a tissue-selective inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme-A reductase. Eur J Biochem 1989,184(3),707-713","journal-title":"Eur J Biochem"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1021\/cr941181o","volume":"97","author":"Nov\u00e1k P.","year":"1997","unstructured":"Nov\u00e1k P.; M\u00fcller K.; Santhanam K.S.; Haas O.; Electrochemically active polymers for rechargeable batteries. Chem Rev 1997,97(1),207-282","journal-title":"Chem Rev"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.jbiotec.2007.05.007","volume":"130","author":"Bizukojc M.","year":"2007","unstructured":"Bizukojc M.; Ledakowicz S.; A macrokinetic modelling of the biosynthesis of lovastatin by Aspergillus terreus. J Biotechnol 2007,130(4),422-435","journal-title":"J Biotechnol"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.btre.2015.12.003","volume":"9","author":"Mouafi F.E.","year":"2016","unstructured":"Mouafi F.E.; Abo Elsoud M.M.; Moharam M.E.; Optimization of biosurfactant production by Bacillus brevis using response surface methodology. Biotechnol Rep (Amst) 2016,9,31-37","journal-title":"Biotechnol Rep (Amst)"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"701","DOI":"10.4103\/0250-474X.49087","volume":"70","author":"Seenivasan A.","year":"2008","unstructured":"Seenivasan A.; Subhagar S.; Aravindan R.; Viruthagiri T.; Microbial production and biomedical applications of lovastatin. Indian J Pharm Sci 2008,70(6),701-709","journal-title":"Indian J Pharm Sci"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0964-8305(00)00063-9","volume":"46","author":"Arai H.","year":"2000","unstructured":"Arai H.; Foxing caused by fungi: twenty-five years of study. Int Biodeterior Biodegradation 2000,46(3),181-188","journal-title":"Int Biodeterior Biodegradation"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1126\/science.1059344","volume":"292","author":"Istvan E.S.","year":"2001","unstructured":"Istvan E.S.; Deisenhofer J.; Structural mechanism for statin inhibition of HMG-CoA reductase. Science 2001,292(5519),1160-1164","journal-title":"Science"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0022-0248(76)90115-9","volume":"32","author":"Oberlin A.","year":"1976","unstructured":"Oberlin A.; Endo M.; Koyama T.; Filamentous growth of carbon through benzene decomposition. J Cryst Growth 1976,32(3),335-349","journal-title":"J Cryst Growth"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.bcab.2017.11.002","volume":"13","author":"Syed M.B.","year":"2018","unstructured":"Syed M.B.; Ponnusamy T.; Bioconversion of mevastatin to pravastatin by various microorganisms and its applications-A review. Biocatal Agric Biotechnol 2018,13,62-74","journal-title":"Biocatal Agric Biotechnol"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0021-9150(80)90124-0","volume":"35","author":"Yamamoto A.","year":"1980","unstructured":"Yamamoto A.; Sudo H.; Endo A.; Therapeutic effects of ML-236B in primary hypercholesterolemia. Atherosclerosis 1980,35(3),259-266","journal-title":"Atherosclerosis"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0092-8674(00)80434-1","volume":"91","author":"Li P.","year":"1997","unstructured":"Li P.; Nijhawan D.; Budihardjo I.; Srinivasula S.M.; Ahmad M.; Alnemri E.S.; Wang X.; Cytochrome C and dATP-dependent formation of Apaf-1\/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997,91(4),479-489","journal-title":"Cell"},{"key":"ref=156","first-page":"29","volume":"7","author":"Samiee S.M.","year":"2003","unstructured":"Samiee S.M.; Moazami N.; Haghighi S.; Aziz Mohseni F.; Mirdamadi S.; Bakhtiari M.R.; Screening of lovastatin production by filamentous fungi. Iran Biomed J 2003,7(1),29-33","journal-title":"Iran Biomed J"},{"key":"ref=157","first-page":"2607","volume":"2","author":"Jaivel N.","year":"2010","unstructured":"Jaivel N.; Marimuthu P.; Isolation and screening of lovastatin producing microorganisms. Int J Eng Sci Technol 2010,2(7),2607-2611","journal-title":"Int J Eng Sci Technol"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"4063","DOI":"10.1007\/s10924-018-1278-4","volume":"26","author":"Suraya N.","year":"2018","unstructured":"Suraya N.; Owolabi F.; Khalil H.A.; Saurabh C.K.; Paridah M.; Asniza M.; Samsul R.; Synergistic effect of oil palm based pozzolanic materials\/oil palm waste on polyester hybrid composite. J Polym Environ 2018,26(10),4063-4072","journal-title":"J Polym Environ"},{"key":"ref=159","first-page":"25","volume":"5","author":"Upendra R.","year":"2013","unstructured":"Upendra R.; Pratima K.; Amiri Z.; Shwetha L.; Ausim M.; Screening and molecular characterization of natural fungal isolates producing lovastatin. J Microb Biochem Technol 2013,5(2),25-30","journal-title":"J Microb Biochem Technol"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"5578","DOI":"10.1002\/jcp.27379","volume":"234","author":"Korani S.","year":"2019","unstructured":"Korani S.; Korani M.; Butler A.E.; Sahebkar A.; Genetics and rheumatoid arthritis susceptibility in Iran. J Cell Physiol 2019,234(5),5578-5587","journal-title":"J Cell Physiol"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1039\/C1CS15060J","volume":"41","author":"Wang G.","year":"2012","unstructured":"Wang G.; Zhang L.; Zhang J.; A review of electrode materials for electrochemical supercapacitors. Chem Soc Rev 2012,41(2),797-828","journal-title":"Chem Soc Rev"},{"key":"ref=162","first-page":"591","volume":"75","author":"Padhye S.G.","year":"2013","unstructured":"Padhye S.G.; Nagarsenker M.S.; Simvastatin solid lipid nanoparticles for oral delivery: Formulation development and in vivo evaluation. Indian J Pharm Sci 2013,75(5),591-598","journal-title":"Indian J Pharm Sci"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1208\/s12249-010-9414-z","volume":"11","author":"Shah M.","year":"2010","unstructured":"Shah M.; Pathak K.; Development and statistical optimization of solid lipid nanoparticles of simvastatin by using 2(3) full-factorial design. AAPS PharmSciTech 2010,11(2),489-496","journal-title":"AAPS PharmSciTech"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/08982104.2015.1137313","volume":"27","author":"Safwat S.","year":"2017","unstructured":"Safwat S.; Hathout R.M.; Ishak R.A.; Mortada N.D.; Augmented simvastatin cytotoxicity using optimized lipid nanocapsules: A potential for breast cancer treatment. J Liposome Res 2017,27(1),1-10","journal-title":"J Liposome Res"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.progpolymsci.2014.02.008","volume":"39","author":"Anitha A.","year":"2014","unstructured":"Anitha A.; Sowmya S.; Kumar P.S.; Deepthi S.; Chennazhi K.; Ehrlich H.; Tsurkan M.; Jayakumar R.; Chitin and chitosan in selected biomedical applications. Prog Polym Sci 2014,39(9),1644-1667","journal-title":"Prog Polym Sci"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.ijbiomac.2014.10.052","volume":"72","author":"Prabaharan M.","year":"2015","unstructured":"Prabaharan M.; Chitosan-based nanoparticles for tumor-targeted drug delivery. Int J Biol Macromol 2015,72,1313-1322","journal-title":"Int J Biol Macromol"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jbiosc.2017.10.011","volume":"125","author":"Zhang B.B.","year":"2018","unstructured":"Zhang B.B.; Xing H.B.; Jiang B.J.; Chen L.; Xu G.R.; Jiang Y.; Zhang D.Y.; Using millet as substrate for efficient production of monacolin K by solid-state fermentation of Monascus ruber. J Biosci Bioeng 2018,125(3),333-338","journal-title":"J Biosci Bioeng"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"959","DOI":"10.4014\/jmb.1303.03026","volume":"23","author":"Lee S.S.","year":"2013","unstructured":"Lee S.S.; Lee J.H.; Lee I.; Strain improvement by overexpression of the laeA gene in Monascus pilosus for the production of monascus-fermented rice. J Microbiol Biotechnol 2013,23(7),959-965","journal-title":"J Microbiol Biotechnol"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jfda.2015.11.008","volume":"24","author":"Dikshit R.","year":"2016","unstructured":"Dikshit R.; Tallapragada P.; Statistical optimization of lovastatin and confirmation of nonexistence of citrinin under solid-state fermentation by Monascus sanguineus. Yao Wu Shi Pin Fen Xi 2016,24(2),433-440","journal-title":"Yao Wu Shi Pin Fen Xi"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1023\/A:1005495714248","volume":"21","author":"Manzoni M.","year":"1999","unstructured":"Manzoni M.; Bergomi S.; Rollini M.; Cavazzoni V.; Production of statins by filamentous fungi. Biotechnol Lett 1999,21(3),253-257","journal-title":"Biotechnol Lett"},{"key":"ref=171","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1039\/p19760001165","volume":"11","author":"Brown A.G.","year":"1976","unstructured":"Brown A.G.; Smale T.C.; King T.J.; Hasenkamp R.; Thompson R.H.; Crystal and molecular structure of compactin, a new antifungal metabolite from Penicillium brevicompactum. J Chem Soc Perkin 1 1976,11,1165-1170","journal-title":"J Chem Soc Perkin 1"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s12010-008-8461-3","volume":"159","author":"Shaligram N.S.","year":"2009","unstructured":"Shaligram N.S.; Singh S.K.; Singhal R.S.; Pandey A.; Szakacs G.; Compactin production studies using Penicillium brevicompactum under solid-state fermentation conditions. Appl Biochem Biotechnol 2009,159(2),505-520","journal-title":"Appl Biochem Biotechnol"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/sj.jim.2900565","volume":"21","author":"Bazaraa W.A.","year":"1998","unstructured":"Bazaraa W.A.; Hamdy M.K.; Toledo R.; Bioreactor for continuous synthesis of compactin by Penicillium cyclopium. J Ind Microbiol Biotechnol 1998,21(4),192-202","journal-title":"J Ind Microbiol Biotechnol"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1021\/np50044a036","volume":"49","author":"Doss S.L.","year":"1986","unstructured":"Doss S.L.; Chu C.K.; Mesbah M.K.; Cutler H.G.; Cole P.D.; Arrendale R.F.; Springer J.P.; Isolation of compactin (a hypocholestrolemic metabolite) from a new source: Penicillium cyclopium. J Nat Prod 1986,49(2),357-358","journal-title":"J Nat Prod"},{"author":"Primrose S.","unstructured":"Primrose S.; King D.; Yaworski E.; Radhakrishnan J.; He D.; Xiao X.U.S.; U.S. Patent US 5,691,173.","key":"ref=175"},{"year":"2001","author":"Chung K.J.","unstructured":"Chung K.J.; Lee J.K.; Lee S.C.; Park J.W.; Seo D.J.; Method for producing pravastatin precursor, ML-236B. U.S. Patent US 6,204,032 B1, March 282001","key":"ref=176"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"6679","DOI":"10.1007\/s13197-014-1678-y","volume":"52","author":"Dikshit R.","year":"2015","unstructured":"Dikshit R.; Tallapragada P.; Bio-synthesis and screening of nutrients for lovastatin by Monascus sp. under solid-state fermentation. J Food Sci Technol 2015,52(10),6679-6686","journal-title":"J Food Sci Technol"}],"container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/173639","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T00:42:43Z","timestamp":1610584963000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/173639\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,22]]},"references-count":177,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2019,11,22]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389201020666190718165746","relation":{},"ISSN":["1389-2010"],"issn-type":[{"type":"print","value":"1389-2010"}],"subject":[],"published":{"date-parts":[[2019,11,22]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-01-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}